• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Insulin-like factor 3 plasma levels in acromegaly before and after somatostatin analog treatment.

作者信息

Rossato Marco, Dassie Francesca, Silvestrin Valentina, Martini Chiara, Vettor Roberto, Maffei Pietro

机构信息

Department of Medicine-DIMED, Clinica Medica 3, University of Padova, School of Medicine, Via Giustiniani 2, 35128, Padova, Italy,

出版信息

Endocrine. 2015 Mar;48(2):705-8. doi: 10.1007/s12020-014-0310-2. Epub 2014 Jun 12.

DOI:10.1007/s12020-014-0310-2
PMID:24917446
Abstract
摘要

相似文献

1
Insulin-like factor 3 plasma levels in acromegaly before and after somatostatin analog treatment.生长激素瘤患者在生长抑素类似物治疗前后的血浆胰岛素样因子3水平。
Endocrine. 2015 Mar;48(2):705-8. doi: 10.1007/s12020-014-0310-2. Epub 2014 Jun 12.
2
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and Switzerland.多中心、观察性研究：兰瑞肽微球在德国、奥地利和瑞士的常规临床实践中治疗肢端肥大症患者。
Exp Clin Endocrinol Diabetes. 2021 Mar;129(3):224-233. doi: 10.1055/a-1247-4713. Epub 2020 Dec 7.
3
Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension.肢端肥大症患者接受兰瑞肽长效微球治疗后血清生长激素和胰岛素样生长因子-1的快速和持续降低：一项随机、安慰剂对照、多中心研究及 52 周开放性扩展。
Pituitary. 2010;13(1):18-28. doi: 10.1007/s11102-009-0191-1. Epub 2009 Jul 29.
4
Lanreotide Autogel for acromegaly: a new addition to the treatment armamentarium.用于肢端肥大症的长效兰瑞肽凝胶：治疗手段的新补充。
Treat Endocrinol. 2004;3(2):77-81. doi: 10.2165/00024677-200403020-00002.
5
Dose and frequency titration of somatostatin analogues in the treatment of acromegaly - an injection of expediency?生长抑素类似物治疗肢端肥大症时的剂量和频率滴定——一种权宜之计的注射方式？
Clin Endocrinol (Oxf). 2001 Jan;54(1):11-3. doi: 10.1046/j.1365-2265.2001.01202.x.
6
Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog).
Am J Cardiol. 1999 May 15;83(10):1506-9, A8. doi: 10.1016/s0002-9149(99)00135-6.
7
Efficacy and tolerability of the long-acting somatostatin analog lanreotide in acromegaly. A 12-month multicenter study of 58 acromegalic patients. French Multicenter Study Group on Lanreotide in Acromegaly.长效生长抑素类似物兰瑞肽治疗肢端肥大症的疗效和耐受性。58例肢端肥大症患者的12个月多中心研究。法国兰瑞肽治疗肢端肥大症多中心研究组
Pituitary. 2000 May;2(4):269-76. doi: 10.1023/a:1009961116472.
8
Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly.生长抑素类似物与聚乙二醇化重组人生长激素受体拮抗剂每周一次联合治疗活动性肢端肥大症。
Lancet. 2005;365(9471):1644-6. doi: 10.1016/S0140-6736(05)63011-5.
9
Cardiovascular effects of a single slow release lanreotide injection in patients with acromegaly and left ventricular hypertrophy.长效兰瑞肽单次缓释注射对肢端肥大症合并左心室肥厚患者的心血管影响
Pituitary. 1999 Nov;2(3):205-10. doi: 10.1023/a:1009997011064.
10
The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly.一种新型缓释长效生长抑素类似物兰瑞肽对肢端肥大症的疗效。
Clin Endocrinol (Oxf). 1996 Oct;45(4):415-21. doi: 10.1046/j.1365-2265.1996.8270836.x.

本文引用的文献

1
Differential expression of somatostatin receptor subtype 1-5 proteins in numerous human normal tissues.生长抑素受体亚型1-5蛋白在多种人类正常组织中的差异表达。
Exp Clin Endocrinol Diabetes. 2012 Sep;120(8):482-9. doi: 10.1055/s-0032-1314859. Epub 2012 Sep 13.
2
Ambulatory arterial stiffness indexes in acromegaly.肢动脉僵硬度指数在肢端肥大症中的变化。
Eur J Endocrinol. 2012 Feb;166(2):199-205. doi: 10.1530/EJE-11-0835. Epub 2011 Nov 29.
3
The novel hormone INSL3 is expressed in human testicular Leydig cell tumors: a clinical and immunohistochemical study.
新型激素 INSL3 在人睾丸间质细胞瘤中的表达：一项临床和免疫组化研究。
Urol Oncol. 2011 Jan-Feb;29(1):33-7. doi: 10.1016/j.urolonc.2008.10.015. Epub 2008 Dec 25.
4
Elevated plasma levels of the novel hormone INSL3 in a woman with metastatic ovarian cancer.一名转移性卵巢癌女性患者血浆中新型激素INSL3水平升高。
Int J Biol Markers. 2007 Apr-Jun;22(2):159-60. doi: 10.1177/172460080702200210.
5
Medical progress: Acromegaly.医学进展：肢端肥大症。
N Engl J Med. 2006 Dec 14;355(24):2558-73. doi: 10.1056/NEJMra062453.
6
The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men.促性腺激素抑制和选择性替代对正常成年男性胰岛素样因子3分泌的影响。
J Clin Endocrinol Metab. 2006 Mar;91(3):1108-11. doi: 10.1210/jc.2005-1865. Epub 2006 Jan 4.
7
Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis.135名正常男性和85名患有睾丸疾病男性的血清胰岛素样因子3水平：与促黄体生成素-睾酮轴的关系
J Clin Endocrinol Metab. 2005 Jun;90(6):3410-8. doi: 10.1210/jc.2004-2257. Epub 2005 Mar 8.
8
A novel circulating hormone of testis origin in humans.一种源自人类睾丸的新型循环激素。
J Clin Endocrinol Metab. 2004 Dec;89(12):5952-8. doi: 10.1210/jc.2004-0575.
9
Testicular growth hormone (GH): GH expression in spermatogonia and primary spermatocytes.睾丸生长激素（GH）：精原细胞和初级精母细胞中的GH表达。
Gen Comp Endocrinol. 2004 Nov;139(2):158-67. doi: 10.1016/j.ygcen.2004.08.002.
10
Testicular descent related to growth hormone treatment.与生长激素治疗相关的睾丸下降
J Pediatr Endocrinol Metab. 2003 Apr-May;16(4):561-3. doi: 10.1515/jpem.2003.16.4.561.